Sugimoto H, Tsuchiya Y, Sugumi H, Higurashi K, Karibe N, Iimura Y, Sasaki A, Araki S, Yamanishi Y, Yamatsu K
Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan.
J Med Chem. 1992 Nov 27;35(24):4542-8. doi: 10.1021/jm00102a005.
Following the discovery of a new series of 1-benzyl-4-[2-(N-benzoyl-N-methylamino)ethyl]piperidine (2) derivatives with a potent anti-acetylcholinesterase (anti-AChE) activity, we extended the structure-activity relationships (SAR) to rigid analogues (4) and 1-benzyl-4-[2-(N-benzoyl-N-phenylamino)ethyl]piperidine derivatives (3). Introduction of a phenyl group on the nitrogen atom of the amide moieties resulted in enhanced activity. The rigid analogue containing isoindolone (9) was found to exhibit potent anti-AChE activity comparable to that of 2. Furthermore, replacement of the isoindolone with other heterobicyclic ring systems was examined. Among the compounds prepared in these series, 1-benzyl-4-[2-[4-(benzoylamino)phthalimido]ethyl]piperidine hydrochloride (19) (IC50 = 1.2 nM) is one of the most potent inhibitors of AChE. Compound 19 showed a definite selectivity to AChE over the BuChE (about 34700-fold) and, at dosages of 10-50 mg/kg, exerted a dose-dependent inhibitory effect on AChE in rat brain.
在发现了一系列具有强效抗乙酰胆碱酯酶(抗AChE)活性的新型1-苄基-4-[2-(N-苯甲酰基-N-甲基氨基)乙基]哌啶(2)衍生物之后,我们将构效关系(SAR)扩展到了刚性类似物(4)和1-苄基-4-[2-(N-苯甲酰基-N-苯基氨基)乙基]哌啶衍生物(3)。在酰胺部分的氮原子上引入苯基导致活性增强。发现含有异吲哚酮的刚性类似物(9)表现出与2相当的强效抗AChE活性。此外,还研究了用其他杂双环系统取代异吲哚酮的情况。在这些系列中制备的化合物中,1-苄基-4-[2-[4-(苯甲酰氨基)邻苯二甲酰亚胺基]乙基]哌啶盐酸盐(19)(IC50 = 1.2 nM)是最有效的AChE抑制剂之一。化合物19对AChE显示出相对于丁酰胆碱酯酶(BuChE)的明确选择性(约34700倍),并且在10-50 mg/kg的剂量下,对大鼠脑中的AChE产生剂量依赖性抑制作用。